This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National Chung Hsing University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations of Sheng-Mei Chen in Stem Cell Research
Introduction
Sheng-Mei Chen is a notable inventor based in Nantou County, Taiwan. He has made significant contributions to the field of stem cell research, particularly in the differentiation of pluripotent stem cells. His work is essential for advancements in regenerative medicine and drug discovery.
Latest Patents
Sheng-Mei Chen holds a patent for a culture medium and method for inducing differentiation of pluripotent stem cells into neuroepithelial cells. The patent describes a culture medium that comprises at least two agents for neural induction, including a Wnt signal agonist and a Smad2/3 inhibitor. This feeder-free culture medium allows for the effective differentiation of pluripotent stem cells into neuroepithelial cells, which can further develop into mature neurons. This innovation has practical applications in regeneration medicine and the treatment of neural disorders.
Career Highlights
Sheng-Mei Chen is affiliated with National Chung Hsing University, where he continues to advance his research in stem cell technology. His work has garnered attention for its potential impact on medical science and therapeutic applications.
Collaborations
Sheng-Mei Chen collaborates with fellow researcher Hong-Lin Su, contributing to the advancement of knowledge in their field.
Conclusion
Sheng-Mei Chen's innovative work in stem cell differentiation represents a significant step forward in regenerative medicine. His contributions are paving the way for new treatments and therapies for neural disorders.